Patent Term Extension Application for VOYDEYA™ (danicopan), Patent No. 9,796,741 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2024-E-3581

Patent Term Extension Application for VOYDEYA™ (danicopan), Patent No. 9,796,741

Documents

Comments

Description

Open

Comment Period OpensAug 9, 2024

Comment Period ClosesAug 16, 2025

Type	Title	Posted	Comments	Status
Other	Letter to U.S. Patent and Trademark Office	Apr 22, 2026	--

CDER

Patent Term Extension Application

Patent No. 9,796,741

VOYDEYA™ (danicopan)

Achillion Pharmaceuticals, Inc.

CLARK & ELBING LLP

Open